loadpatents
name:-0.034490823745728
name:-0.10148906707764
name:-0.035378217697144
Meetze; Kristan Patent Filings

Meetze; Kristan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Meetze; Kristan.The latest application filed is for "glycan-interacting compounds and methods of use".

Company Profile
4.13.18
  • Meetze; Kristan - Lexington MA
  • Meetze; Kristan - Walpole MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Glycan-Interacting Compounds and Methods of Use
App 20220057402 - da Silva; Ana Paula Galvao ;   et al.
2022-02-24
Glycan-Interacting Compounds and Methods of Use
App 20210011021 - da Silva; Ana Paula Galvao ;   et al.
2021-01-14
Anti-erbb3 Antibodies
App 20200299406 - Vincent; Sylvie ;   et al.
2020-09-24
Glycan-Interacting Compounds and Methods of Use
App 20200276306 - da Silva; Ana Paula Galvao ;   et al.
2020-09-03
Anti-ERBB3 antibodies
Grant 10,494,441 - Vincent , et al. De
2019-12-03
Platinum compounds, compositions, and uses thereof
Grant 10,322,137 - Bilodeau , et al.
2019-06-18
Glycan-interacting Compounds And Methods Of Use
App 20180280504 - da Silva; Ana Paula Galvao ;   et al.
2018-10-04
Predicting Tumor Response To Anti-erbb3 Antibodies
App 20180195120 - Vincent; Sylvie ;   et al.
2018-07-12
Platinum compounds, compositions, and uses thereof
Grant 9,937,187 - Bilodeau , et al. April 10, 2
2018-04-10
Anti-erbb3 Antibodies
App 20180030149 - Vincent; Sylvie ;   et al.
2018-02-01
Platinum Compounds, Compositions, And Uses Thereof
App 20180008614 - Bilodeau; Mark T. ;   et al.
2018-01-11
Predicting tumor response to anti-ERBB3 antibodies
Grant 9,828,635 - Vincent , et al. November 28, 2
2017-11-28
Glycan-interacting Compounds And Methods Of Use
App 20170306046 - daSilva; Ana Paula Galvao ;   et al.
2017-10-26
Anti-erbb3 Antibodies
App 20160264679 - Vincent; Sylvie ;   et al.
2016-09-15
Anti-ErbB3 antibodies
Grant 9,228,021 - Vincent , et al. January 5, 2
2016-01-05
Anti-ron antibodies
Grant 8,829,164 - Whalen , et al. September 9, 2
2014-09-09
Predicting Tumor Response To Anti-erbb3 Antibodies
App 20140242597 - Vincent; Sylvie ;   et al.
2014-08-28
Anti-ron Antibodies
App 20140066603 - Whalen; Kerry ;   et al.
2014-03-06
Anti-erbb3 Antibodies
App 20130330772 - Vincent; Sylvie ;   et al.
2013-12-12
Anti-RON antibodies
Grant 8,603,478 - Whalen , et al. December 10, 2
2013-12-10
Anti-fgfr2 Antibodies
App 20130288305 - Weng; Zhigang ;   et al.
2013-10-31
Anti-FGFR2 antibodies
Grant 8,481,688 - Weng , et al. July 9, 2
2013-07-09
Anti-ErbB3 antibodies
Grant 8,481,687 - Vincent , et al. July 9, 2
2013-07-09
Fibroblast growth factor receptor 3 (FGFR3) binding proteins
Grant 8,187,601 - Weng , et al. May 29, 2
2012-05-29
Anti-ron Antibodies
App 20120027773 - Whalen; Kerry ;   et al.
2012-02-02
Anti-fgfr2 Antibodies
App 20110305687 - Weng; Zhigang ;   et al.
2011-12-15
Anti-erbb3 Antibodies
App 20110256154 - Vincent; Sylvie ;   et al.
2011-10-20
Fibroblast Growth Factor Receptor 3 (fgfr3) Binding Proteins
App 20100003258 - Weng; Zhigang ;   et al.
2010-01-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed